September 26, 2007 / 11:25 AM / 11 years ago

CollaGenex says incyclinide ineffective for rosacea

NEW YORK, Sept 26 (Reuters) - CollaGenex Pharmaceuticals Inc CGPI.O said on Wednesday it is abandoning development of its drug incyclinide for treating rosacea after a Phase 2 study found it was ineffective at reducing lesions.

In the trial of 197 rosacea patients, the drug did not demonstrate a greater reduction in inflammatory lesions than the patients on a placebo, the company said.

CollaGenex said it plans to conduct additional development work for the use incyclinide to treat acne. (Reporting by Chris Reiter)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below